ECRIN ERIC, in which HECRIN is a full member, is a nonprofit organization classified as “landmark” on the ESFRI Roadmap, aims to support noncommercial, scientific, multi-center drug development research in Europe. The HECRIN Consortium supports the strengthening of the research potential and its implementation through accredited processes. The consortium promotes the continuous professional training as well as efforts to utilize the clinical data assets for research purposes
Members of the HECRIN Consortium:
HECRIN supports the strengthening of research potential and its implementation through accredited processes. It promotes ongoing professional training as well as efforts to utilize clinical data assets for research purposes. The aim is to bring to the surface the potential of Hungary in innovative, high-quality clinical research.
The most important tasks of the Consortium are the creation of professionally established clinical trial units (CTUs) in the institutions of the consortium members, the initiation and support of high-quality Hungarian academic examinations, and the operation of the national center at the University of Pécs. Operational support for the conduct of academic, multinational clinical trials in Hungary, related management activities, provision of services (monitoring, regulatory approvals, pharmacovigilance, etc.), on the other hand, embracing Hungarian academic clinical trial initiatives.
Through these services, the participation of Hungarian researchers in European multinational clinical trials will increase, the national clinical trial infrastructure will be strengthened, and research activity will increase. Hungarian researchers have access to the ECRIN certification program and data centers.